Odyssey Health (ODYY) Receivables (2016 - 2024)

Odyssey Health (ODYY) posted quarterly Receivables of $22625.0 for Q3 2024, up 2050.67% quarter-over-quarter from $1052.0 in Q4 2017.

Odyssey Health (ODYY) Receivables (2016 - 2024) Analysis & Trends

Odyssey Health's Receivables history runs 3 years deep, the most recent figure standing at $22625.0 for Q3 2024.

In Q3 2024, Receivables changed N/A year-over-year to $22625.0; the TTM figure through Jul 2024 stood at $22625.0 (changed N/A YoY), while the FY2024 annual figure was -$231316.0, changed N/A from the prior year.
Receivables for Q3 2024 stood at $22625.0, up from $1052.0 in the prior quarter.
The five-year high for Receivables was $22625.0 in Q3 2024, with the low at $22625.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	8.60 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	3.74 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	6.64 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	3.18 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	955.70 Mn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	1.28 Bn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	4.66 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	4.12 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	1.01 Bn
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Download Data